Yoji Hyodo

10PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesNanotoxicology, health and safetySurgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 19, 2026
Prognostic Significance of the Modified Glasgow Prognostic Score and Systemic Immune-Inflammation Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel.

|Mar 14, 2026
Real-World Safety and Early Effectiveness of First-Line Enfortumab Vedotin Plus Pembrolizumab with Routine Dexamethasone Premedication in Advanced Urothelial Carcinoma.

Takuto Hara, Naoto Wakita, Taisuke Tobe

|Feb 13, 2026
Kidney transplantation after chronic active Epstein-Barr virus infection remission.

Yuki Tashiro, Yoji Hyodo, Satoshi Kitamura

|Jan 18, 2026
Prognostic Impact of Initial Prostate Specific Antigen Half-Life After Abiraterone Acetate in High-Volume Metastatic Hormone-Sensitive Prostate Cancer: Who May Need Triplet Therapy?

Kotaro Suzuki, Hideto Ueki, Naoto Wakita

|Sep 03, 2025
Hepatitis B Boosters Using a Different Product vs. the Same Product for Kidney Transplant Recipients: A Retrospective Study With Bayesian Inference.

Kentaro Iwata, Shunkichi Ikegaki, Yoji Hyodo

|Sep 03, 2025
Nomogram for Predicting the Survival Outcome of Cabazitaxel Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multi-Institutional Analysis.

Kotaro Suzuki, Junichiro Hirata, Hideto Ueki

Pageof 2

Frequent Collaborators

6 joint publications

Kotaro Suzuki

6 joint publications

Takuto Hara

6 joint publications

Tomoaki Terakawa

5 joint publications

Jun Teishima